T-cell Acute Lymphoblastic Leukemia

DBCOND0065733Hemic and Lymphatic DiseasesImmune System Diseases

T-cell Acute Lymphoblastic Leukemia is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
T-cell Adult Acute Lymphoblastic Leukemia · Leukemia, Lymphoblastic, Acute, T-cell · Adult Acute Lymphocytic Leukemia T-Cell · Adult T Acute Lymphoblastic Leukemia · Leukemia, Lymphocytic, Acute, T-Cell
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0502869SNOMED CT128824003MedDRA10042987UMLSC1961099

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
97Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for T-cell Acute Lymphoblastic Leukemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In